FDA Authorization Is Not Federal Deployment Readiness

FDA AUTHORIZATION ANSWERS A DIFFERENT QUESTION

FDA authorization allows a medical device to be marketed, but it does not ensure federal agencies are ready to purchase, deploy, or support it. Successful federal adoption requires procurement access, technical readiness, operational planning, and ongoing lifecycle support.

A 510(k) clearance, De Novo authorization, premarket approval (PMA), or applicable exemption establishes a product’s status under the Federal Food, Drug, and Cosmetic Act. It may permit the device to be commercially marketed for its authorized or legally supported intended use. It does not determine whether the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service, or another federal organization can purchase, connect, install, support, or routinely order it.

A Purchasing Path Must Exist

Federal facilities do not buy every authorized device through the same mechanism. Depending on the agency, product, and transaction, access may require a Federal Supply Schedule contract, Distribution and Pricing Agreement and Medical Prime Vendor participation, Electronic Catalog position, agency solicitation, open-market purchase, blanket purchase agreement, prime contractor, or authorized distributor.

The responsible seller may also need active federal registrations, current representations, accurate catalog records, contract-compliant pricing, and ordering data.

Even when a purchasing vehicle exists, availability is not the same as adoption. A facility may still require clinical sponsorship, product evaluation, funding, standardization review, value analysis, or approval from local and enterprise stakeholders.

A product that cannot be found under the correct identifier, unit of measure, package configuration, price, or ordering channel may remain practically unavailable. VA’s contract catalog, for example, includes Federal Supply Schedule items and national contract vehicles that ordering activities use to identify available products.

Connection and Installation Require Separate Review

Connected devices, software-enabled products, and systems that store or transmit sensitive information may face technical review before purchase or deployment.

The manufacturer may need to provide network architecture, data-flow diagrams, ports and protocols, cloud dependencies, cybersecurity documentation, software versions, patching and vulnerability-management processes, remote-access controls, interface specifications, and contingency operating procedures.

VA Directive 6550, for example, establishes pre-procurement assessment and implementation controls for relevant medical devices and systems. DoD medical equipment programs similarly address procurement, cybersecurity, sustainment, interoperability, and lifecycle management as separate operational responsibilities. Products containing information and communication technology may also require a Section 508 accessibility analysis.

Deployment Depends on Physical and Operational Compatibility

Deployment also depends on physical and operational compatibility. Facilities may need to confirm electrical, environmental, space, mounting, wireless, interface, sterilization, calibration, and workflow requirements.

Vendor personnel may require facility credentials or controlled access before demonstrations, installation, training, maintenance, or case support can occur.

Readiness Continues After Installation

Federal customers may evaluate the complete lifecycle: delivery, installation, acceptance testing, training, warranty, preventive maintenance, software support, cybersecurity updates, replacement parts, complaint escalation, recalls, field actions, and end-of-life planning.

Routine ordering also depends on reliable inventory, lead times, catalog maintenance, invoicing, and service coverage.